Biotech

All Articles

Biogen's chief executive officer mentioned no risky sell 2023. He's ready to be strong

.While Biogen's pharma peers are hunting for late-stage possessions with little bit of danger, CEO C...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has actually been a biotech looking for a pipe after it scrapped its own lead asse...

Biogen bows out Denali Alzheimer's collab

.Biogen has restored civil rights to an early Alzheimer's condition course to Denali Therapeutics, l...

Takeda taps brand new mind people oncology business-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and r...

Vertex, hammered by AATD once again, drops 2 resources on throw out pile

.Tip's effort to address an uncommon hereditary illness has reached yet another trouble. The biotech...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits report wasn't except big information. The company welcomed a t...

Galapagos pauses CAR-T cell therapy hearing over Parkinsonism instance

.Galapagos has actually stopped briefly enrollment in a test of a BCMA-directed CAR-T cell treatment...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After much more than 30 years, gene treatment pioneer James Wilson M.D., Ph.D., is leaving the Coll...

3 biotechs make an effort to beat the summer season warm through shedding team

.As biotechs try to switch a fresh page in August, at least three business have actually dropped tea...

venBio elevates $528M for 5th life sciences VC fund

.Veteran venture capital agency venBio has actually lifted one more half a billion bucks to purchase...